New German bill to end pharmaceutical price "manipulation" in Germany
This article was originally published in Scrip
Executive Summary
The German authorities will seek compensation from pharmaceutical companies that "manipulated" their medicine prices in order to try to offset the discounts that they were obliged to offer to health insurers. The provision is part of Germany's new bill on the Reorganization of the Pharmaceutical Market (Arzneimittelmarkt-Neuordnungsgesetz; Amnog)which was last week finalised by the parliament and which will come into effect in January 2011.